Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2019
Total Assets: $57.47B
Liabilities Breakdown FY2019
Total Liabilities: $42.41B
Asset Breakdown
Total Assets: $57.47B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.98B | 3.4% |
| Accounts Receivable | $5.68B | 9.9% |
| Inventory | $4.42B | 7.7% |
| Property, Plant & Equipment | $6.44B | 11.2% |
| Goodwill | $24.85B | 43.2% |
| Intangible Assets | $11.23B | 19.5% |
| Other Assets | $2.88B | 5.0% |
Liabilities Breakdown
Total Liabilities: $42.41B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.72B | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $40.69B | 95.9% |